Yinyin I. Yuan
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Deconvolution of Sparse-count RNA Sequencing Data for Tumor Cells Using Embedded Negative Binomial Distributions.
Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025
Histopathology-based Spatial Profiling of Immune and Molecular Features Predicts Cancer risk in Barrett's Esophagus.
Journal: medRxiv : the preprint server for health sciences
Published: November 26, 2025
Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.
Journal: The Lancet. Oncology
Published: November 17, 2025
Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 04, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).
Journal: Journal for immunotherapy of cancer
Published: August 27, 2025
The state of the art in artificial intelligence and digital pathology in prostate cancer.
Journal: Nature reviews. Urology
Published: July 08, 2025
Gompertz growth with a shared carrying capacity optimally simulates primary and metastatic tumor growth dynamics.
Journal: British journal of cancer
Published: July 03, 2025
Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer.
Journal: Cell reports. Medicine
Published: May 27, 2025
Density-adjusted analysis of cell interactions to decipher tissue landscape changes.
Journal: iScience
Published: May 07, 2025
Dysregulated SASS6 expression promotes increased ciliogenesis and cell invasion phenotypes.
Journal: Life science alliance
Published: May 13, 2024
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.
Journal: Research square
Published: January 03, 2024
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.
Journal: NPJ precision oncology
Published: December 04, 2023
Last Updated: 09/26/2026